To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Novorapid is a bolus insulin analogue created by Novo Nordisk. It is of rDNA origin.
Additional recommended knowledge
It has become a widely-used replacement for the now defunct Actrapid insulin, as it has very similar properties. One problem with this insulin though is that it has to be administered in double the quantity that Actrapid was, although this is only a small problem.
It has a reaction time of around 25 - 35 minutes, depending on the physical size of the person taking it. This means it is known as "fast-acting".
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Novorapid". A list of authors is available in Wikipedia.|